Literature DB >> 28102829

Absorbed dose evaluation of Auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values.

Nadia Falzone1, Boon Q Lee, José M Fernández-Varea, Christiana Kartsonaki, Andrew E Stuchbery, Tibor Kibédi, Katherine A Vallis.   

Abstract

The aim of this study was to investigate the impact of decay data provided by the newly developed stochastic atomic relaxation model BrIccEmis on dose point kernels (DPKs - radial dose distribution around a unit point source) and S-values (absorbed dose per unit cumulated activity) of 14 Auger electron (AE) emitting radionuclides, namely 67Ga, 80mBr, 89Zr, 90Nb, 99mTc, 111In, 117mSn, 119Sb, 123I, 124I, 125I, 135La, 195mPt and 201Tl. Radiation spectra were based on the nuclear decay data from the medical internal radiation dose (MIRD) RADTABS program and the BrIccEmis code, assuming both an isolated-atom and condensed-phase approach. DPKs were simulated with the PENELOPE Monte Carlo (MC) code using event-by-event electron and photon transport. S-values for concentric spherical cells of various sizes were derived from these DPKs using appropriate geometric reduction factors. The number of Auger and Coster-Kronig (CK) electrons and x-ray photons released per nuclear decay (yield) from MIRD-RADTABS were consistently higher than those calculated using BrIccEmis. DPKs for the electron spectra from BrIccEmis were considerably different from MIRD-RADTABS in the first few hundred nanometres from a point source where most of the Auger electrons are stopped. S-values were, however, not significantly impacted as the differences in DPKs in the sub-micrometre dimension were quickly diminished in larger dimensions. Overestimation in the total AE energy output by MIRD-RADTABS leads to higher predicted energy deposition by AE emitting radionuclides, especially in the immediate vicinity of the decaying radionuclides. This should be taken into account when MIRD-RADTABS data are used to simulate biological damage at nanoscale dimensions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28102829     DOI: 10.1088/1361-6560/aa5aa4

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

1.  Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018.

Authors:  Nadia Falzone; Rebecca Gregory; Matthew Aldridge; Samantha Ya Terry; Glenn Flux
Journal:  Br J Radiol       Date:  2019-05-20       Impact factor: 3.039

2.  In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab.

Authors:  Muhamad Faiz Bin Othman; Elise Verger; Ines Costa; Meena Tanapirakgul; Margaret S Cooper; Cinzia Imberti; Valerie J Lewington; Philip J Blower; Samantha Y A Terry
Journal:  Nucl Med Biol       Date:  2019-12-13       Impact factor: 2.408

Review 3.  Subcellular Targeting of Theranostic Radionuclides.

Authors:  Bas M Bavelaar; Boon Q Lee; Martin R Gill; Nadia Falzone; Katherine A Vallis
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.988

4.  Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.

Authors:  Elise Verger; Jordan Cheng; Vittorio de Santis; Madeleine Iafrate; Jessica A Jackson; Cinzia Imberti; Gilbert O Fruhwirth; Philip J Blower; Michelle T Ma; Daniel R Burnham; Samantha Y A Terry
Journal:  Nucl Med Biol       Date:  2021-06-15       Impact factor: 2.408

Review 5.  Auger electrons for cancer therapy - a review.

Authors:  Anthony Ku; Valerie J Facca; Zhongli Cai; Raymond M Reilly
Journal:  EJNMMI Radiopharm Chem       Date:  2019-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.